Award
NIH Reporter #3K23AI182453-03S1
The development & pilot implementation of a CRISPR-based low-cost point-of-care assay for detecting Neisseria gonorrhoeae and molecular markers of antimicrobial resistance in resource-limited settings
Recipient
Lao-Tzu Allan-Blitz
Award Amount
$43,171.00
Ceiling
$43,171.00
Awarded
September 17, 2026
Identifier
3K23AI182453-03S1
Award to develop and pilot a CRISPR-based assay for detecting Neisseria gonorrhoeae and antimicrobial resistance in resource-limited settings, supporting career development of Dr. Lao-Tzu Allan-Blitz.
Description
This project aims to develop and evaluate a CRISPR-based low-cost point-of-care assay for detecting Neisseria gonorrhoeae and antimicrobial resistance markers, with a focus on resource-limited settings such as Botswana. The award supports Dr. Lao-Tzu Allan-Blitz’s career development in STI assay development and implementation.